| Assay ID | Title | Year | Journal | Article |
|---|
| AID1126536 | Antiproliferative activity against human SKBR3 cells assessed as cell viability after 72 hrs by CCK8 assay | 2014 | European journal of medicinal chemistry, May-06, Volume: 78 | Design, synthesis and bioevaluation of N-trisubstituted pyrimidine derivatives as potent aurora A kinase inhibitors. |
| AID1126537 | Antiproliferative activity against human A549 cells assessed as cell viability after 72 hrs by CCK8 assay | 2014 | European journal of medicinal chemistry, May-06, Volume: 78 | Design, synthesis and bioevaluation of N-trisubstituted pyrimidine derivatives as potent aurora A kinase inhibitors. |
| AID1126527 | Inhibition of Aurora A (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition measured after 60 mins | 2014 | European journal of medicinal chemistry, May-06, Volume: 78 | Design, synthesis and bioevaluation of N-trisubstituted pyrimidine derivatives as potent aurora A kinase inhibitors. |
| AID1126532 | Antiproliferative activity against human U937 cells assessed as cell viability after 72 hrs by CCK8 assay | 2014 | European journal of medicinal chemistry, May-06, Volume: 78 | Design, synthesis and bioevaluation of N-trisubstituted pyrimidine derivatives as potent aurora A kinase inhibitors. |
| AID1126538 | Antiproliferative activity against human A431 cells assessed as cell viability after 72 hrs by CCK8 assay | 2014 | European journal of medicinal chemistry, May-06, Volume: 78 | Design, synthesis and bioevaluation of N-trisubstituted pyrimidine derivatives as potent aurora A kinase inhibitors. |
| AID1126533 | Antiproliferative activity against human MOLT4 cells assessed as cell viability after 72 hrs by CCK8 assay | 2014 | European journal of medicinal chemistry, May-06, Volume: 78 | Design, synthesis and bioevaluation of N-trisubstituted pyrimidine derivatives as potent aurora A kinase inhibitors. |
| AID1126521 | Antiproliferative activity against human PANC1 cells assessed as cell viability after 72 hrs by CCK8 assay | 2014 | European journal of medicinal chemistry, May-06, Volume: 78 | Design, synthesis and bioevaluation of N-trisubstituted pyrimidine derivatives as potent aurora A kinase inhibitors. |
| AID1126530 | Antiproliferative activity against human HL60 cells assessed as cell viability after 72 hrs by CCK8 assay | 2014 | European journal of medicinal chemistry, May-06, Volume: 78 | Design, synthesis and bioevaluation of N-trisubstituted pyrimidine derivatives as potent aurora A kinase inhibitors. |
| AID1126542 | Antiproliferative activity against human NCI-N87 cells assessed as cell viability after 72 hrs by CCK8 assay | 2014 | European journal of medicinal chemistry, May-06, Volume: 78 | Design, synthesis and bioevaluation of N-trisubstituted pyrimidine derivatives as potent aurora A kinase inhibitors. |
| AID1126531 | Antiproliferative activity against human K562 cells assessed as cell viability after 72 hrs by CCK8 assay | 2014 | European journal of medicinal chemistry, May-06, Volume: 78 | Design, synthesis and bioevaluation of N-trisubstituted pyrimidine derivatives as potent aurora A kinase inhibitors. |
| AID1126541 | Antiproliferative activity against human HeLa cells assessed as cell viability after 72 hrs by CCK8 assay | 2014 | European journal of medicinal chemistry, May-06, Volume: 78 | Design, synthesis and bioevaluation of N-trisubstituted pyrimidine derivatives as potent aurora A kinase inhibitors. |
| AID1126535 | Antiproliferative activity against human MDA-MB-231 cells assessed as cell viability after 72 hrs by CCK8 assay | 2014 | European journal of medicinal chemistry, May-06, Volume: 78 | Design, synthesis and bioevaluation of N-trisubstituted pyrimidine derivatives as potent aurora A kinase inhibitors. |
| AID1126534 | Antiproliferative activity against human MCF7 cells assessed as cell viability after 72 hrs by CCK8 assay | 2014 | European journal of medicinal chemistry, May-06, Volume: 78 | Design, synthesis and bioevaluation of N-trisubstituted pyrimidine derivatives as potent aurora A kinase inhibitors. |
| AID1126543 | Antiproliferative activity against human HCT116 cells assessed as cell viability after 72 hrs by CCK8 assay | 2014 | European journal of medicinal chemistry, May-06, Volume: 78 | Design, synthesis and bioevaluation of N-trisubstituted pyrimidine derivatives as potent aurora A kinase inhibitors. |
| AID1126540 | Antiproliferative activity against human PC3 cells assessed as cell viability after 72 hrs by CCK8 assay | 2014 | European journal of medicinal chemistry, May-06, Volume: 78 | Design, synthesis and bioevaluation of N-trisubstituted pyrimidine derivatives as potent aurora A kinase inhibitors. |
| AID1126539 | Antiproliferative activity against human DU145 cells assessed as cell viability after 72 hrs by CCK8 assay | 2014 | European journal of medicinal chemistry, May-06, Volume: 78 | Design, synthesis and bioevaluation of N-trisubstituted pyrimidine derivatives as potent aurora A kinase inhibitors. |
| [information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |